Clinical and laboratory measures of disease activity in systemic sclerosis.

被引：0
|
作者：
Veale, DJ
Fearon, UM
Henshaw, K
Johnston, H
Reay, N
Pope, J
Furst, DE
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1644
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [41] HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis
    Pietilainen, J.
    Virtanen, J. O.
    Uotila, L.
    Salonen, O.
    Koskiniemi, M.
    Farkkila, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 506 - 509
  • [42] Microhaemorrages and Giant Capillaries in Nailfold Videocapillariscopies Are Able to Accurately Predict Disease Activity Level in Systemic Sclerosis.
    Sambataro, Domenico
    Del Papa, Nicoletta
    Sambataro, Gianluca
    Maglione, Wanda
    Zaccara, Eleonora
    Vitali, Claudio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S744 - S744
  • [43] Anti-DNA topoisomerase I antibody IgG titer correlates with disease activity in systemic sclerosis.
    Hu, PQ
    Fertig, N
    Medsger, TA
    Wright, TM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S326 - S326
  • [44] Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report
    Valentini, Gabriele
    Iudici, Michele
    Jaeger, Veronika K.
    Denton, Christopher P.
    Distler, Oliver
    Kowal-Bielecka, Otylia M.
    Mueller-Ladner, Ulf
    Riemekasten, Gabriela
    Walker, Ulrich A.
    Jordan, Suzana
    Siegert, Elise
    Vettori, Serena
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.
    Rigamonti, C
    Shand, L
    Maurille, F
    Bunn, C
    Burroughs, AK
    HEPATOLOGY, 2004, 40 (04) : 466A - 466A
  • [46] VIDEOFLUOROSCOPY SWALLOW STUDY IN PATIENTS WITH SYSTEMIC SCLEROSIS. CORRELATION WITH CLINICAL PATTERNS
    Fraticelli, P.
    Fischetti, C.
    Pisani, A. M.
    Barchiesi, S.
    Romanelli, G.
    Gabrielli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 906 - 906
  • [47] Assessment of disease outcome measures in systemic sclerosis
    Lafyatis, Robert
    Valenzi, Eleanor
    NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (09) : 527 - 541
  • [48] Assessment of disease outcome measures in systemic sclerosis
    Robert Lafyatis
    Eleanor Valenzi
    Nature Reviews Rheumatology, 2022, 18 : 527 - 541
  • [49] PUVA therapy of skin sclerosis in systemic sclerosis and limited sclerosis.
    Griffiths, B
    Murphy, A
    Smith, J
    Veale, DJ
    Emery, P
    Goodfield, M
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S190 - S190
  • [50] Ability of commonly used outcome measures to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
12345